ARCHIVES

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

This article is from The Cancer Letter archive.

Vol. 18 No. 33 | August 14, 1992

Download PDF Visit The Full Archive

Related Articles

Relative Survival Now May be Over 50%, DeVita Says

December 3, 1982

AACR Campaigns For Doubling Funding for Cancer Research In Three Years

April 25, 1997

FDA Places Controls On Silicone Implants, Though Still Available For Reconstruction

April 25, 1992

In Brief: House Passes Bill Extending Saccharin Status To 1981; Execs No Enthusiastic Over New SES

August 3, 1979

Long-Term Results Find Cisplatin Improves Survival

May 25, 2007

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

June 30, 2000